Health Services · Medical/Nursing Services · NSE: NIDAN · data 2026-10-09

Nidan Laboratories and Healthcare Limited

Health check: Weak (3.9/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹13.25

Market cap

₹19 cr

P/E

12.3

P/B

—

ROE

2.2%

ROCE

4.0%

Debt / equity

0.16

Dividend yield

0.00%

1-year return

-28.0%

52-week high

₹24.9

52-week low

₹11.5

Operating margin

11.5%

Growth

Revenue (last 12 months)	₹26 cr
Net profit (last 12 months)	₹2 cr
Sales growth, 3 years (yearly)	1.7%
Profit growth, 3 years (yearly)	-24.8%

Similar companies

CHANDAN HEALTHCARE LIMITED (CHANDAN) · Rays of Belief Limited (MOMSBELIEF) · Pramodini Medicare Limited (PRAMODINI) · Lotus Eye Hospital And Institute Ltd (LOTUSEYE) · Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open NIDAN in NSE Scanner →